Literature DB >> 10207430

Hepatic lesion detection: comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis.

J Ward1, K S Naik, J A Guthrie, D Wilson, P J Robinson.   

Abstract

PURPOSE: To compare the performance of magnetic resonance (MR) imaging after the administration of superparamagnetic iron oxide (SPIO) and dual-phase computed tomography (CT) in the depiction of liver metastases.
MATERIALS AND METHODS: Fifty-one hepatic resection candidates with known colorectal metastases were examined. MR imaging comprised fast spin-echo (SE) T2-weighted imaging, T1-weighted gradient-echo (GRE) fast low-angle shot imaging before SPIO enhancement, dual-echo SE imaging, T2-weighted fast low-angle shot imaging, and T1-weighted GRE imaging after SPIO enhancement. CT was performed with 8-mm collimation and 1:1 pitch; imaging commenced 20 seconds and 65-70 seconds after injection of 150 mL of contrast medium. All images were reviewed independently by four blinded observers. The alternative-free response receiver operating characteristic (ROC) method was used to analyze the results, which were correlated with findings from surgery, intraoperative ultrasonography, and histopathologic studies in 31 patients and with consensus review together with all other imaging and clinical follow-up in 20 patients. Sensitivities were also calculated.
RESULTS: The mean sensitivity of MR was significantly higher than that of CT (p < .02): 79.8% for MR and 75.3% for CT for all lesions, and 80.6% for MR and 73.5% for CT for malignant lesions. The mean areas under the alternative-free response ROC curves were 0.83 for MR and 0.78 for CT (difference not significant).
CONCLUSION: SPIO-enhanced MR imaging was more sensitive than dual-phase CT in the depiction of colorectal metastases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10207430     DOI: 10.1148/radiology.210.2.r99fe05459

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  40 in total

1.  The role of MRI in pancreatic cancer.

Authors:  Philip A Robinson
Journal:  Eur Radiol       Date:  2001-10-16       Impact factor: 5.315

Review 2.  What is the current situation in liver imaging?

Authors:  M M Uggowitzer
Journal:  Eur Radiol       Date:  2003-11       Impact factor: 5.315

Review 3.  [Modern imaging for liver metastases from colorectal tumors].

Authors:  J Gaa; H Wieder; M Schwaiger; E J Rummeny
Journal:  Chirurg       Date:  2005-06       Impact factor: 0.955

4.  Comparison of contrast-enhanced ultrasonography versus baseline ultrasound and contrast-enhanced computed tomography in metastatic disease of the liver: diagnostic performance and confidence.

Authors:  Emilio Quaia; Mirko D'Onofrio; Alessandro Palumbo; Stefania Rossi; Stefano Bruni; Maria Cova
Journal:  Eur Radiol       Date:  2006-03-22       Impact factor: 5.315

Review 5.  The impact of new technology on surgery for colorectal cancer.

Authors:  G B Makin; D J Breen; J R Monson
Journal:  World J Gastroenterol       Date:  2001-10       Impact factor: 5.742

6.  Clinical management of hepatic malignancies: ferucarbotran-enhanced magnetic resonance imaging versus contrast-enhanced spiral computed tomography.

Authors:  Riccardo Lencioni; Clotilde Della Pina; Jordi Bruix; Pietro Majno; Luigi Grazioli; Giovanni Morana; Antonella Filippone; Andrea Laghi; Carlo Bartolozzi
Journal:  Dig Dis Sci       Date:  2005-03       Impact factor: 3.199

Review 7.  The role of surgery in the therapeutic approach of gastric cancer liver metastases.

Authors:  Aikaterini Mastoraki; Christina Benetou; Sotiria Mastoraki; Ioannis S Papanikolaou; Nikolaos Danias; Vassilios Smyrniotis; Nikolaos Arkadopoulos
Journal:  Indian J Gastroenterol       Date:  2016-08-16

Review 8.  Imaging of liver cancer.

Authors:  Ben Ariff; Claire R Lloyd; Sameer Khan; Mohamed Shariff; Andrew V Thillainayagam; Devinder S Bansi; Shahid A Khan; Simon D Taylor-Robinson; Adrian K P Lim
Journal:  World J Gastroenterol       Date:  2009-03-21       Impact factor: 5.742

Review 9.  Current treatment for liver metastases from colorectal cancer.

Authors:  Lian-Xin Liu; Wei-Hui Zhang; Hong-Chi Jiang
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

10.  Sensitivity of magnetic resonance imaging in the detection of colorectal liver metastases.

Authors:  S Blyth; A Blakeborough; M Peterson; I C Cameron; A W Majeed
Journal:  Ann R Coll Surg Engl       Date:  2008-01       Impact factor: 1.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.